Search results for "Colorectal Neoplasms."

showing 10 items of 431 documents

Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan

2007

Objective: We designed this trial to investigate if modifications in levels of circulating vascular endothelial growth factor (VEGF) may be related to clinical response and outcome in advanced colorectal cancer patients during treatment with a weekly combination of cetuximab plus irinotecan. Methods: A total of 45 heavily pretreated metastatic colorectal cancer patients were prospectively evaluated for circulating levels of VEGF during the treatment with cetuximab plus weekly irinotecan. VEGF circulating levels were assessed at the following time points: just before and at 1, 21, 50 and 92 days after the start of cetuximab plus irinotecan treatment. Results: Basal VEGF median levels were s…

AdultMaleVascular Endothelial Growth Factor AOncologymedicine.medical_specialtyAngiogenesisColorectal cancerCetuximabAntibodies Monoclonal HumanizedIrinotecanangiogenesiscetuximabcolorectal canceririnotecansurvivalvascular endothelial growth factorBasal (phylogenetics)chemistry.chemical_compoundInternal medicineAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumorGeneticsmedicineHumansProspective StudiesProspective cohort studyAgedPharmacologyCetuximabbusiness.industryAntibodies MonoclonalMiddle Agedmedicine.diseaseSurvival RateClinical trialVascular endothelial growth factorIrinotecanTreatment OutcomechemistryDisease ProgressionMolecular MedicineCamptothecinFemaleColorectal Neoplasmsbusinessmedicine.drugPharmacogenomics
researchProduct

Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients

2006

INTRODUCTION Angiogenesis has been correlated with increased invasion and metastases in a variety of human neoplasms. Inadequate inhibition of the growth of tumor microvessels by anticancer agents may result in treatment failure, rated clinically as progressive or stable disease. We designed this trial to investigate the modification of the vascular endothelial growth factor (VEGF) and interferon-gamma (IFN-gamma) in advanced colorectal cancer patients during treatment with a weekly combination of cetuximab plus irinotecan. MATERIALS AND METHODS Forty-five metastatic colorectal cancer patients were prospectively evaluated for circulating levels of VEGF and IFN-gamma during the treatment wit…

AdultMaleVascular Endothelial Growth Factor Amedicine.medical_specialtyAngiogenesisColorectal cancerCetuximabAntibodies Monoclonal HumanizedIrinotecanGastroenterologyNeovascularizationInterferon-gammaBasal (phylogenetics)chemistry.chemical_compoundangiogenesis cetuximab colorectal cancer irinotecanInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective StudiesProspective cohort studyAgedNeovascularization PathologicCetuximabbusiness.industryAntibodies MonoclonalHematologyMiddle Agedmedicine.diseaseVascular endothelial growth factorIrinotecanTreatment OutcomeEndocrinologyOncologychemistryCamptothecinFemalemedicine.symptomColorectal Neoplasmsbusinessmedicine.drug
researchProduct

High definition plus colonoscopy combined with i-scan tone enhancement vs. high definition colonoscopy for colorectal neoplasia: A randomized trial

2014

High definition endoscopy is the accepted standard in colonoscopy. However, an important problem is missed polyps.Our objective was to assess the additional adenoma detection rate between high definition colonoscopy with tone enhancement (digital chromoendoscopy) vs. white light high definition colonoscopy.In this prospective randomized trial patients were included to undergo a tandem colonoscopy. The first exam was a white light colonoscopy with removal of all visualized polyps. The second examination was randomly assigned in a 1:1 ratio as either again white light colonoscopy (Group A) or colonoscopy with tone enhancement (Group B). Primary endpoint was the adenoma detection rate during t…

AdultMalemedicine.medical_specialtyAdenomaColonoscopyAdenocarcinomaSensitivity and SpecificityGastroenterologyStatistics Nonparametriclaw.inventionChromoendoscopyHospitals UniversityRandomized controlled triallawGermanyInternal medicineImage Interpretation Computer-AssistedmedicineWhite lightClinical endpointHumansProspective StudiesAgedChi-Square DistributionHepatologymedicine.diagnostic_testbusiness.industryHigh definition endoscopyGastroenterologySignal Processing Computer-AssistedColonoscopyMiddle AgedImage Enhancementmedicine.diseaseLogistic ModelsHigh definitionFemaleRadiologyColorectal NeoplasmsbusinessDigestive and Liver Disease
researchProduct

Prognostic factors for cryotherapy of colorectal liver metastases.

2004

Abstract Background . Cryotherapy is a local ablative treatment option for non-resectable liver tumours. We aimed to identify prognostic indicators, that may allow better selection or stratification for adjuvant therapies of patients. Methods . Fifty-five patients had cryotherapy for colorectal liver metastases. The patient-, tumour- and operative details were recorded prospectively. Mean follow up was 24 months. A uni- and multivariate analysis for possible prognostic factors was performed. Results . There was a trend towards better survival for patients with unilobar liver metastases, preoperative serum levels of carcinoembrional antigen (CEA) not exceeding 20 ng/ml and patients undergoin…

AdultMalemedicine.medical_specialtyBlood transfusionMultivariate analysisColorectal cancermedicine.medical_treatmentCryotherapyGastroenterologyCryosurgeryCryosurgeryInternal medicinemedicineHumansAgedUnivariate analysisbusiness.industryProportional hazards modelLiver NeoplasmsGeneral MedicineMiddle Agedmedicine.diseasePrognosisSurgeryCarcinoembryonic AntigenSurvival RateOncologySurgeryFemalebusinessColorectal NeoplasmsAdjuvantBiomarkersEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
researchProduct

Computed Virtual Chromoendoscopy for Classification of Small Colorectal Lesions: A Prospective Comparative Study

2007

Standard colonoscopy offers no reliable discrimination between neoplastic and nonneoplastic colorectal lesions. Computed virtual chromoendoscopy with the Fujinon intelligent color enhancement (FICE) system is a new dyeless imaging technique that enhances mucosal and vascular patterns. This prospective trial compared the feasibility of FICE, standard colonoscopy, and conventional chromoendoscopy with indigo carmine in low- and high-magnification modes for determination of colonic lesion histology.Sixty-three patients with 150 flat or sessile lesions less than 20 mm in diameter were enrolled. At colonoscopy, each lesion was observed with six different endoscopic modalities: standard colonosco…

AdultMalemedicine.medical_specialtyColonic PolypsRectumIndigo CarmineSensitivity and SpecificityChromoendoscopyPredictive Value of TestsImage Processing Computer-AssistedmedicineHumansColoring AgentsAgedAged 80 and overObserver VariationHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyColonoscopyMiddle AgedImage EnhancementEndoscopymedicine.anatomical_structureFemaleRadiologyColorectal NeoplasmsbusinessColonography Computed TomographicThe American Journal of Gastroenterology
researchProduct

Incidence, Presentation, and Prognosis of Small Bowel Adenocarcinoma in Patients with Small Bowel Crohn's Disease: A Prospective Observational Study.

2013

International audience; BACKGROUND:: Patients with Crohn's disease (CD) of the colon are at risk for colorectal cancer and should be screened for dysplasia and cancer of the colon. Small bowel adenocarcinoma (SBA) is a complication of small bowel CD and carries a poor prognosis. However, there is no screening test for SBA in patients with small bowel CD. The aim of this study was to assess the risk and incidence of SBA in a large prospective cohort of patients with small bowel CD and to compare it with the risk of colorectal cancer in patients with CD involving the colon, recruited in the same cohort. METHODS:: In a nationwide French cohort, 11,759 patients with CD were enrolled by 680 gast…

AdultMalemedicine.medical_specialtyColorectal cancerPopulationAdenocarcinomaGastroenterology03 medical and health sciences0302 clinical medicineCrohn DiseaseInterquartile rangeRisk Factors[ CHIM.ORGA ] Chemical Sciences/Organic chemistryInternal medicinemedicineImmunology and AllergyHumansProspective StudieseducationProspective cohort studyCrohn's diseaseeducation.field_of_studybusiness.industry[CHIM.ORGA]Chemical Sciences/Organic chemistryIncidence (epidemiology)IncidenceGastroenterologyCancerMiddle Agedmedicine.diseasePrognosisdigestive system diseasesIleal Neoplasms030220 oncology & carcinogenesisCohort030211 gastroenterology & hepatologyFemaleFrancebusinessColorectal NeoplasmsFollow-Up Studies
researchProduct

Cryotherapy for liver metastases

2000

Cryotherapy is undergoing a renaissance in the treatment of nonresectable liver tumors. In a prospective case control study we assessed the morbidity, mortality, and efficacy of hepatic cryotherapy for liver metastases. Between January 1996 and September 1999 a total of 54 cryosurgical procedures were performed on 49 patients (median age 66 years, 21 women) with liver metastases. Patient, tumor, and operative details were recorded prospectively. Liver metastases originated from colorectal cancer (n=37), gastric cancer (n=3), renal cell carcinoma (n=2), and other primaries (n=7). Median follow-up was 13 months (1-32). The median number of liver metastases was 3 (range 1-10) with a median dia…

AdultMalemedicine.medical_specialtyColorectal cancermedicine.medical_treatmentCryotherapyCryosurgeryMetastasisStomach NeoplasmsRenal cell carcinomaInternal medicinemedicineHumansProspective StudiesAgedTumor markerbusiness.industryLiver NeoplasmsGastroenterologyCancerCryoablationMiddle AgedHepatologymedicine.diseaseSurgeryTreatment OutcomeCase-Control StudiesFemaleMorbidityNeoplasm Recurrence LocalColorectal NeoplasmsbusinessInternational Journal of Colorectal Disease
researchProduct

Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery

2005

Background: Population based colorectal cancer survival among patients diagnosed in 1985–89 was lower in Europe than in the USA (45% v 59% five year relative survival). Aims: To explain this difference in survival using a new analytic approach for patients diagnosed between 1990 and 1991. Subjects: A total of 2492 European and 11 191 US colorectal adenocarcinoma patients registered by 10 European and nine US cancer registries. Methods: We obtained clinical information on disease stage, number of lymph nodes examined, and surgical treatment. We analysed three year relative survival, calculating relative excess risks of death (RERs, referent category US patients) adjusted for age, sex, site, …

AdultMalemedicine.medical_specialtyColorectal cancerpopulation based cancer registriescolorectal cancerAdenocarcinomasurvivalsurgerylymph nodesmedicineHumansRegistriesStage (cooking)Risk factorUSASurvival analysisAgedNeoplasm StagingColorectal CancerRelative survivalcolorectal cancer; population based cancer registries; surgery; lymph nodes; survival; USA; Europebusiness.industryGastroenterologyAbsolute risk reductionCancerMiddle Agedmedicine.diseaseSurvival AnalysisUnited StatesConfidence intervalSurgeryEuropeLymphatic MetastasisFemaleColorectal NeoplasmsbusinessGut
researchProduct

Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years

2019

ObjectiveThe incidence of colorectal cancer (CRC) declines among subjects aged 50 years and above. An opposite trend appears among younger adults. In Europe, data on CRC incidence among younger adults are lacking. We therefore aimed to analyse European trends in CRC incidence and mortality in subjects younger than 50 years.DesignData on age-related CRC incidence and mortality between 1990 and 2016 were retrieved from national and regional cancer registries. Trends were analysed by Joinpoint regression and expressed as annual percent change.ResultsWe retrieved data on 143.7 million people aged 20–49 years from 20 European countries. Of them, 187 918 (0.13%) were diagnosed with CRC. On averag…

AdultMalemedicine.medical_specialtyJoinpoint regressionColorectal cancerYoung Adult03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingRegional cancerEpidemiologyHumansMedicineYoung adultRetrospective Studiesbusiness.industryIncidenceIncidence (epidemiology)GastroenterologyMiddle Agedmedicine.diseaseAnnual Percent Change3. Good healthEuropeSurvival RateYounger adults030220 oncology & carcinogenesisFemale030211 gastroenterology & hepatologyColorectal NeoplasmsbusinessFollow-Up StudiesForecastingDemographyGut
researchProduct

Retrospective Analysis of 29 Patients with Multiple Pulmonary Metastases from Colorectal Carcinoma Resected by a 1318-nm Laser

2018

NO Abstract

AdultMalemedicine.medical_specialtyLung NeoplasmsColorectal cancerTreatment outcomeMEDLINEColorectal Neoplasm030204 cardiovascular system & hematologyFollow-Up Studie03 medical and health sciences0302 clinical medicineRetrospective StudiePositron Emission Tomography Computed TomographyRetrospective analysisMedicineHumansPneumonectomyPositron Emission Tomography-Computed TomographyRetrospective StudiesAgedNeoplasm StagingAged 80 and overbusiness.industryFollow up studiesMetastasectomyRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseLung NeoplasmTreatment OutcomeThoracotomy030220 oncology & carcinogenesisNeoplasm stagingFemaleRadiologyLaser TherapybusinessColorectal NeoplasmsFollow-Up StudiesHuman
researchProduct